Lori Boies, Ph.D., MPH, has made significant contributions to the fields of bioinformatics, cancer biology, public health, and science education. Her early research at UT Southwestern advanced neuro-oncology by developing and characterizing two novel inducible transgenic mouse models, leading to the identification of distinct populations of adult neural stem cells and transient progenitors that persist into advanced age. She later conducted a genome‑wide association study focused on genetic variants potentially linked to cardiotoxicity in childhood cancer survivors, further broadening her impact on translational health research. Beyond the laboratory, Dr. Boies plays an active role in national science education initiatives, serving on committees for the National Institute on Scientific Teaching and the Genomics Education Partnership, where she is the Vice Chair of the Assessment Committee for 2025–2026.
Dr. Boies currently serves as a Research Assistant Professor of Biological Sciences (Bioinformatics) at St. Mary’s University, where she teaches across bioinformatics, genomics, and public health. She is the Program Director for the undergraduate Bioinformatics Program and is leading the launch of the Master of Science in Medical Genomics Program, scheduled to begin in Fall 2026. Her mentorship focuses on student research in gene annotation, epidemiology, and biostatistics, and she maintains leadership roles in national education networks that advance genomics pedagogy.
Her academic preparation reflects deep interdisciplinary training. Dr. Boies earned her Ph.D. in Cancer Biology from the University of Texas Southwestern Medical Center at Dallas, preceded by a B.S. in Biochemistry (Honors) with a minor in Biology from Angelo State University, where she graduated magna cum laude and completed research as a Carr Research Fellow and Welch Scholar. While on faculty, she expanded her expertise by completing an M.P.H. in Epidemiology and a Graduate Certificate in Genomics and Bioinformatics from the UTHealth School of Public Health.